StemCell Institute
TSE:7096
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
StemCell Institute
Net Income (Common)
StemCell Institute
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
StemCell Institute
TSE:7096
|
Net Income (Common)
¥385.8m
|
CAGR 3-Years
42%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
E
|
Elan Corp
TSE:6099
|
Net Income (Common)
¥2.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
14%
|
CAGR 10-Years
23%
|
|
|
Solasto Corp
TSE:6197
|
Net Income (Common)
¥4.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
BML Inc
TSE:4694
|
Net Income (Common)
¥7.6B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
5%
|
|
|
H.U. Group Holdings Inc
TSE:4544
|
Net Income (Common)
¥5.6B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
France Bed Holdings Co Ltd
TSE:7840
|
Net Income (Common)
¥2.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
StemCell Institute
Glance View
StemCell Institute KK engages in stem cell banking business. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 82 full-time employees. The company went IPO on 2021-06-25. The firm operates Cell Bank business segment. After signing the contract for the separation and storage of umbilical cord blood with customers (pregnant women), the umbilical cord blood collected at domestic umbilical cord blood collection cooperative hospitals (university hospitals, obstetric clinics and others) is collected, and carried into its cell processing center in Minato-ku, Tokyo. The company will be stored at its own cell storage center (Midori-ku, Yokohama, Kanagawa) for a long time at ultra-low temperature after stem cells contained in cord blood being separated, extracted and prepared.
See Also
What is StemCell Institute's Net Income (Common)?
Net Income (Common)
385.8m
JPY
Based on the financial report for Mar 31, 2025, StemCell Institute's Net Income (Common) amounts to 385.8m JPY.
What is StemCell Institute's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
7%
Over the last year, the Net Income (Common) growth was 24%. The average annual Net Income (Common) growth rates for StemCell Institute have been 42% over the past three years , 7% over the past five years .
